DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Qatar Investment Authority
Qatar Investment Authority
CandidateUS
no sworn venture fact yet (name or round mention only)
Importance
4
low
Active deployment
11
low
Emerging
0
low
Completeness
6
low
Freshness
97
high
Research priority
5
low
Identity and regulatory footprint
- Headquarters
- unknown
- Office address
- unknown
- Business phone
- unknown
- Website
- unknown
- SEC adviser type
- unknown
- SEC exemption claimed
- unknown
- Latest Form ADV
- unknown
- Private funds reported
- unknown
- Private fund gross assets
- unknownreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Stated thesis versus observed behaviour
3 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 50%series c 50%
Stage at first entry
series b 50%series c 50%
Sectors
unknown 67%Other 33%
lead rate 33%follow-on rate 0%new logos, 12 months 3
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
0 current, 0 departed
No named professional yet. People arrive from Form ADV Schedule A (owners, officers, control persons) and the team page.
Investments on record
3 edges, 3 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Positron AI, Inc. | Funding round | participant | unknown | $875M | unknown | Sep 10, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
| Akura Medical, a Shifamed Portfolio Company | Series C · Series C | lead | unknown | $53.0M | unknown | Dec 1, 2025 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
| Kailera Therapeutics | Series B · Series B | participant | unknown | $600M | unknown | Oct 14, 2025 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
24 relationships from shared deals, counted for the whole firm
Unless Management LP 1 shared · one timeFincadia Advisors 1 shared · one timeResilience Reserve 1 shared · one timeNEA 1 shared · one time · they led 1Atreides Management, LP 1 shared · one time · they led 1Arena Private Wealth 1 shared · one timeBoardman Bay Capital Management LLC 1 shared · one timeDFJ Growth 1 shared · one timeHudson River Trading 1 shared · one timeNatural Capital 1 shared · one timeHelena 1 shared · one timeFlume Ventures Management, LLC 1 shared · one timeBanyan Ventures 1 shared · one timeCanada Pension Plan Investment Board 1 shared · one timeRTW Investments 1 shared · one timePerseverance Capital 1 shared · one timeInvus 1 shared · one timeKailera 1 shared · one timeBain Capital Life Sciences 1 shared · one timeRoyalty Pharma 1 shared · one timeBain Capital Private Equity 1 shared · one timeAtlas Venture 1 shared · one timeAdage Capital Management 1 shared · one timeSurveyor Capital 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
0 dated events
No dated event yet.
Classification history
- Sep 12, 2026Candidate (candidate, 50%, cls-1)no sworn venture fact yet (name or round mention only)
- Sep 12, 2026Candidate (candidate, 50%, press-1)named as an investor in a financing announcement
Evidence
0 observations from 0 sources
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|